Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

10.990
-0.110-0.99%
Volume:3.22M
Turnover:35.44M
Market Cap:28.22B
PE:17.45
High:11.100
Open:11.180
Low:10.960
Close:11.100
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:0.63
T/O Rate:0.13%
Dividend:0.21
Dividend Rate:1.91%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.57
PE(LYR):17.45
PS:2.77

Loading ...

先声药业2025年度业绩:营收同比增16.5%至77.31亿元 净利润大幅提升86.2%

Bulletin Express
·
Apr 28

Simcere Pharma’s 2025 ESG Report: 2.08 Billion RMB R&D Outlay, 22% Carbon-Intensity Cut and Strong Gender Parity

Bulletin Express
·
Apr 28

Simcere Pharmaceutical Publishes 2025 Annual Report and ESG Report, Implements Full Electronic Dissemination

Bulletin Express
·
Apr 28

Simcere Pharma Publishes 2025 Annual Report, Switches to Electronic Communication for Shareholders

Bulletin Express
·
Apr 28

Simcere Pharmaceutical publishes 2025 ESG report

Reuters
·
Apr 28

BRIEF-Simcere Pharma Withdraws NDA For Rademikibart, Expects To Resubmit Within April 2026

Reuters
·
Apr 22

SIMCERE PHARMA Withdraws and Plans to Resubmit New Drug Application for Ledokibart This Month

Stock News
·
Apr 22

Simcere Pharma to Resubmit NDA for Rademikibart; Phase 3 Data Show 96.6% EASI-75 at Week 52

Bulletin Express
·
Apr 22

Simcere Pharmaceutical - to Seek Regulatory Approval for Rademikibart Market Launch

THOMSON REUTERS
·
Apr 22

Simcere Pharmaceutical - Pharma Withdraws Nda for Rademikibart, Expects to Resubmit Within April 2026

THOMSON REUTERS
·
Apr 22

Simcere withdraws, plans to resubmit rademikibart atopic dermatitis NDA within month

Reuters
·
Apr 22

Assessing Simcere Pharmaceutical Group (SEHK:2096) Valuation After Strong 2025 Earnings Report

Simply Wall St.
·
Apr 08

SIMCERE PHARMA Keeps Share Base Steady in March 2026; Public Float Above 15.45% Threshold

Bulletin Express
·
Apr 02

Bocom International Raises SIMCERE PHARMA (02096) Target Price to HK$17.7, Keeps "Buy" Rating

Stock News
·
Mar 30

Assessing Simcere Pharmaceutical Group’s Valuation After Strong Earnings And Positive SIM0237 Cancer Trial Results

Simply Wall St.
·
Mar 30

Simcere Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
Mar 29

Stock Track | SIMCERE PHARMA Soars 7.87% in Morning Session on New CEO Appointment and Strong Financial Results

Stock Track
·
Mar 27

SIMCERE PHARMA Shares Surge Nearly 8% in Morning Session Following Appointment of Former HENGRUI PHARMA Chairman as CEO

Stock News
·
Mar 27

Simcere Pharmaceutical FY2026 RSU awards climb to 2.2 million; HKD 11.18 closing price holds on grant date

Reuters
·
Mar 26

SIMCERE PHARMA Invests HK$22.03 Million in Share Buyback

Stock News
·
Mar 26